Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Pregnant woman between 18 and 40 years of age~* Have depression as their only mental health disorder~* Have been receiving fluoxetine or citalopram for the treatment of depression for at least one month on the day of study entry for patients in the fluoxetine and citalopram arms, or no pharmacological treatment for patients in the control arm~* ≤ 26 weeks pregnant by estimated date of confinement~* Ability to give informed consent~* Singleton pregnancy~* Pregnant women no history of depression~Exclusion Criteria:~* Having any comorbid mental disorder other than generalized anxiety disorder as a secondary disorder~* History of or current epilepsy, endocrine, cardiac, pulmonary, renal or hepatic dysfunction that could negatively influence pregnancy and/or neonatal outcome~* Abusing alcohol or drugs~* Use of any self prescribed herbal treatments for depression

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: None): Pregnant women currently taking Prozac for the treatment of depression
- 2 (Type: None): Pregnant women currently taking Zoloft for the treatment of depression
- 3 (Type: None): Pregnant women not currently using medication for the treatment of depression
- 4 (Type: None): Pregnant women with no history of, symptoms of, or treatment for depression

Based on this trial design, predict the completion outcome and termination type (if applicable).